Treatment of Mild Spondylitis
Start with NSAIDs as first-line pharmacological treatment, combined with physical therapy—this is the strongly recommended initial approach for all patients with active axial spondyloarthritis, regardless of disease severity 1, 2.
Initial Management Algorithm
First-Line Treatment (All Patients)
NSAIDs:
- Any NSAID is acceptable; no specific agent is preferred 2
- For mild/active disease: Use continuous NSAID therapy (not on-demand) to control symptoms 1, 2
- Trial period: Consider NSAID failure after 1 month of continuous use (at least two different NSAIDs for 15 days each) 1
- Important caveat: Once disease is stable/controlled, switch to on-demand NSAIDs rather than continuous use 2
- Consider selective COX-2 inhibitors in patients at high risk for gastrointestinal adverse events 1
Physical Therapy (Equally Important):
- Strongly recommended alongside NSAIDs 2
- Prioritize active/supervised exercise programs over passive modalities (massage, ultrasound, heat) 2
- Land-based exercises are preferred over aquatic therapy 2
- Patients should perform regular unsupervised back exercises at home 2
What NOT to Do
Avoid systemic glucocorticoids - this is a strong recommendation against their use in axial disease 1, 2. The risks outweigh benefits for long-term management.
Do not use conventional DMARDs (sulfasalazine, methotrexate) for pure axial involvement—these should only be considered if prominent peripheral arthritis is present 2.
When to Escalate Beyond NSAIDs
For mild spondylitis that remains active despite adequate NSAID trial (defined above), escalation criteria require:
- ASDAS ≥2.1 (indicating persistent active disease) 3
- AND failed ≥2 NSAIDs
- AND objective evidence of inflammation: elevated CRP, MRI inflammation of sacroiliac joints, or radiographic sacroiliitis 3
If these criteria are met, advance to biologic therapy (TNF inhibitors or IL-17 inhibitors) 2, 3.
Monitoring Strategy
- Use ASDAS (Ankylosing Spondylitis Disease Activity Score) at regular intervals 1
- Monitor CRP and/or ESR as inflammatory markers 1
- Do not routinely use MRI or radiographs for follow-up monitoring 1—these are for diagnosis, not routine surveillance
Key Clinical Pitfalls
Don't undertreate with on-demand NSAIDs initially: For active disease, continuous NSAIDs are more effective than as-needed dosing 1, 2
Don't continue continuous NSAIDs indefinitely: Once stable, switch to on-demand to minimize long-term NSAID exposure 2
Don't skip physical therapy: This is not optional—it's a core treatment component with strong evidence for improving mobility, function, and quality of life 2
Don't use systemic steroids as a shortcut: Despite their anti-inflammatory effects, the evidence does not support their use in axial disease 1, 2
The most recent 2023 PANLAR guidelines 1 and 2022 ASAS-EULAR update 3 emphasize that for truly mild disease responding to NSAIDs and physical therapy, this combination remains the appropriate long-term management without need for escalation to biologics.